36 research outputs found
Self-trapped electrons and holes in PbBr crystals
We have directly observed self-trapped electrons and holes in PbBr
crystals with electron-spin-resonance (ESR) technique. The self-trapped states
are induced below 8 K by two-photon interband excitation with pulsed
120-fs-width laser light at 3.10 eV. Spin-Hamiltonian analyses of the ESR
signals have revealed that the self-trapping electron centers are the dimer
molecules of Pb along the crystallographic a axis and the
self-trapping hole centers are those of Br with two possible
configurations in the unit cell of the crystal. Thermal stability of the
self-trapped electrons and holes suggests that both of them are related to the
blue-green luminescence band at 2.55 eV coming from recombination of spatially
separated electron-hole pairs.Comment: 8 pages (7 figures, 2 tables), ReVTEX; revised the text and figures
1, 4, and
Self-trapped states and the related luminescence in PbCl crystals
We have comprehensively investigated localized states of photoinduced
electron-hole pairs with electron-spin-resonance technique and
photoluminescence (PL) in a wide temperature range of 5-200 K. At low
temperatures below 70 K, holes localize on Pb ions and form
self-trapping hole centers of Pb. The holes transfer to other trapping
centers above 70 K. On the other hand, electrons localize on two Pb ions
at higher than 50 K and form self-trapping electron centers of Pb.
From the thermal stability of the localized states and PL, we clarify that
blue-green PL band at 2.50 eV is closely related to the self-trapped holes.Comment: 8 pages (10 figures), ReVTEX; removal of one figure, Fig. 3 in the
version
Role of continuous glucose monitoring in the management of diabetic pregnancy
Self-monitoring of blood glucose (SMBG) with intermittent capillary glucose fingerstick tests is currently the universally accepted method of glucose monitoring in pregnancy. During pregnancy SMBG tests are recommended before and after meals and before bed (typically 7 values/d). Continuous glucose monitoring systems consist of a disposable subcutaneous glucose-sensing device, electrochemically measuring glucose levels in subcutaneous tissues every 10 seconds, providing an average interstitial glucose value every 5 minutes (typically 288 values/d). From a research perspective this provides unprecedented insights into the pathophysiology of glucose metabolism, while from a clinical perspective it can facilitate enhanced patient-professional decision making, patient motivation, and improved glycaemic control. CGM has thus been described as a "roadmap for effective self-management" and as a "stepping stone in the journey towards a cure." This review will consider the lessons learned and evidence supporting current and potential future use of CGM in the management of diabetes in pregnancy